Michael Celano, Chief Financial Officer at Larimar Therapeutics, Inc. (LRMR), bought 5,000 shares at $3.73 ($19K) on 2023-05-17, disclosed to the SEC on 2023-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| OSUR | SELL | 2017-05-09 | $1.3M | — | Filing → |
| OSUR | SELL | 2017-03-06 | $180K | — | Filing → |
| OSUR | SELL | 2017-02-13 | $101K | — | Filing → |